Market cap
$822 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
64
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -652.90 | -494.65 | -128.48 | -195.25 | -215.65 |
| Net Profit | -635.34 | -487.90 | -126.19 | -191.31 | -216.02 |
| EPS | -319.78 | -118.07 | -6.13 | 14.47 | 10.85 |
| Book Value | -- | -- | -33.30 | -13.00 | -41.86 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-25 | Dec-24 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -17,520.92 | -- | -- | -- |
| Return on equity
| -512.35 | -373.64 | -- | -257.67 | -409.51 |
| Return on Capital
| -161.62 | -138.12 | -- | -162.33 | -172.64 |
| Return on Assets
| -131.36 | -115.42 | -51.11 | -135.90 | -137.33 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.70 | 0.48 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
--
|
-162.33
|
-172.64
|
-149.88
|
-124.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
--
|
-257.67
|
-409.51
|
-869.88
|
-230.43
|
|
Peer Median
|
-40.29
|
--
|
--
|
--
|
--
|
ROA
-51.11
Lower than Peers by 20.28
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
-51.11
|
-135.90
|
-137.33
|
-120.85
|
-108.08
|
|
Peer Median
|
-30.84
|
--
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-82.21
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
--
|
--
|
--
|
--
|
-17,520.92
|
|
Peer Median
|
-89.88
|
--
|
--
|
--
|
--
|
Revenue Growth
--
--
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
54.03
|
--
|
--
|
--
|
--
|
EBIT Growth
-128.48
Lower than Peers by 127.52
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
-128.48
|
-42.98
|
-39.63
|
33.92
|
-23.29
|
|
Peer Median
|
-0.95
|
--
|
--
|
--
|
--
|
Net Profit Growth
-126.19
Lower than Peers by 119.01
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
-126.19
|
-37.21
|
-33.58
|
28.80
|
-27.27
|
|
Peer Median
|
-7.19
|
--
|
--
|
--
|
--
|
EPS Growth
-6.13
Lower than Peers by 20.57
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
-6.13
|
0.11
|
0.18
|
0.54
|
0.11
|
|
Peer Median
|
14.43
|
--
|
--
|
--
|
--
|
Book Value Growth
-113.06
Lower than Peers by 102.60
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
-113.06
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.46
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
--
|
0.70
|
0.48
|
-11.55
|
1.95
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-0.51
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
-0.51
|
0.17
|
0.00
|
-11.55
|
1.94
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.95
Lower than Peers by 4.85
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
0.95
|
4.39
|
5.46
|
0.82
|
1.27
|
|
Peer Median
|
5.80
|
--
|
--
|
--
|
--
|
Quick Ratio
0.95
Lower than Peers by 4.74
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
0.95
|
--
|
--
|
--
|
1.38
|
|
Peer Median
|
5.69
|
--
|
--
|
--
|
--
|
Interest Coverage
-113.73
Lower than Peers by 111.64
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
-113.73
|
-65.73
|
-17.27
|
-9.45
|
-22.81
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.07
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
--
|
--
|
--
|
-3,993.72
|
-3,858.34
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
--
|
2,256.38
|
2,047.95
|
1,824.65
|
1,935.36
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
--
|
-4.85
|
-3.05
|
-2.92
|
-0.79
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
64.03
Higher than Peers by 58.68
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
64.03
|
12.31
|
5.81
|
-60.22
|
3.99
|
|
Peer Median
|
5.35
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-2.42
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
-2.42
|
-4.54
|
-2.59
|
-3.31
|
-0.61
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
822
Higher than Peers by 675
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-25
|
Dec-24
|
Dec-23
|
Dec-22
|
|---|---|---|---|---|---|
|
Achieve Life Sciences (ACHV)
|
822
|
--
|
--
|
--
|
--
|
|
Peer Median
|
147
|
--
|
--
|
--
|
--
|